Delve into the kinase inhibitors' diverse landscape, from cancer breakthroughs to autoimmune disease innovations.

During development, cells grow, expand, and migrate to generate tissues and organs in a highly controlled manner. Many ...

It is likely that PI3K inhibitors will need to be used in combination with other drugs that induce cell stress, such as other signaling inhibitors, radio- and chemotherapy. Points at which ...

Recently, the research team led by Professor Zhang Zhongtao and Professor Yao Hongwei from the General Surgery Center at ...

A fireside chat at the 24 th Annual Needham Virtual Healthcare Conference at 11:00 a.m. ET on Thursday, April 10, 2025. A live webcast will be available using this weblink: ...

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Some people taking BTK inhibitors have developed skin cancer or other cancers. Doctors recommend protecting your skin while on these medications to lower this risk. PI3K is another protein ...

Seth Wander, MD, PhD, discusses genomic variations effect on elacestrant in ESR1-mutated breast cancer from findings in real-world data.

The company licenced its PI3 kinase inhibitors to the top biotech company Genentech for use in cancer, and in 2008, Piramed was acquired by Roche to develop the inhibitors for inflammatory diseases.